Christopher John Hamilton Porter

Title: Innovations of Christopher John Hamilton Porter

Introduction

Christopher John Hamilton Porter is an accomplished inventor based in Port Melbourne, Australia. He holds a total of four patents, showcasing his significant contributions to the field of macromolecular science. His work focuses on the development of innovative macromolecules with controlled stoichiometry and functional properties.

Latest Patents

One of his latest patents is titled "Modified macromolecule." This invention relates to a macromolecule that features a controlled terminal group stoichiometry. The macromolecule includes a surface layer, at least one subsurface layer, and at least two terminal groups. The first terminal group is a residue of a pharmaceutically active agent, while the second terminal group is selected to modify the pharmacokinetics of the active agent and/or macromolecule. Terminal group stoichiometry refers to the number and type of terminal groups present in the macromolecule.

Another significant patent is "Macromolecular compounds having controlled stoichiometry." This invention is directed towards macromolecules that possess controlled stoichiometry and topology. It details processes for their production and applications for their use. The macromolecules have a controlled functional moiety stoichiometry and include at least one dendritic motif. This motif has a surface layer formed from at least one surface building unit and at least one subsurface layer formed from at least one building unit. The building units have a hydrocarbon backbone bearing a carbonyl group and at least one amine group, along with at least two different functional moieties.

Career Highlights

Christopher Porter is currently employed at Starpharma Pty Limited, where he continues to innovate in the field of macromolecular research. His work has been instrumental in advancing the understanding and application of macromolecules in pharmaceuticals.

Collaborations

Throughout his career, Christopher has collaborated with notable colleagues, including Guy Yeoman Krippner and Pasquale Razzino. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Christopher John Hamilton Porter is a prominent inventor whose work in macromolecular science has led to significant advancements in the field. His innovative patents reflect his dedication to improving pharmacological applications through controlled macromolecular design.